| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | A | A | $59.34B | $3.21B | $151.92M | $43.57M | $0.31 | 53.24% | 51.59% | N/A | N/A | |
| CALX | CALIX INC | A | A | $3.89B | $933.69M | $10.21M | -$7.25M | -$0.10 | 4.89% | 13.70% | N/A | N/A | |
| MYRG | MYR GROUP INC | A | A | $3.56B | $3.51B | $214.54M | $97.82M | $6.21 | -0.64% | 9.71% | 168.83% | 14.11% | |
| AKBA | AKEBIA THERAPEUTICS INC | A | A | $443.16M | $225.07M | $25.70M | -$15.91M | -$0.08 | 32.49% | -6.09% | N/A | N/A | |
| TVTX | TRAVERE THERAPEUTICS INC | A | A | $3.09B | $435.83M | -$22.58M | -$88.54M | -$1.03 | 114.22% | 17.57% | N/A | N/A | |
| AORT | ARTIVION INC | A | A | $2.17B | $422.65M | $48.31M | -$9.14M | -$0.23 | 9.81% | 10.63% | N/A | N/A | |
| PGY | PAGAYA TECHNOLOGIES LTD | A | A | $1.97B | $1.25B | -$155.79M | -$193.59M | -$2.74 | 28.33% | N/A | N/A | N/A | |
| TPC | TUTOR PERINI CORP | A | A | $3.12B | $5.10B | $108.27M | -$27.83M | -$0.54 | 19.22% | -0.17% | N/A | N/A | |
| ARLO | ARLO TECHNOLOGIES INC | A | A | $1.50B | $509.57M | $8.23M | $4.30M | $0.04 | -2.83% | 6.92% | N/A | N/A | |
| INNV | INNOVAGE HOLDING CORP | A | A | $656.70M | $884.66M | $7.04M | -$17.37M | -$0.12 | 12.48% | N/A | N/A | N/A | |
| OPFI | OPPFI INC | A | A | $848.94M | $376.43M | $60.51M | $3.87M | -$0.07 | 22.85% | N/A | N/A | N/A | |
| PATH | UIPATH INC | A | A | $7.45B | $1.50B | $44.98M | $20.17M | $0.03 | 8.25% | N/A | N/A | N/A | 2025-12-04 |
| EHAB | ENHABIT INC | A | A | $409.41M | $1.05B | $51.00M | -$11.90M | -$0.24 | 1.02% | N/A | N/A | N/A | |
| FENC | FENNEC PHARMACEUTICALS INC | A | A | $221.00M | $38.79M | -$4.53M | -$6.94M | -$0.25 | -21.39% | N/A | N/A | N/A | |
| ORGO | ORGANOGENESIS HOLDINGS INC | A | A | $774.16M | $465.22M | $18.04M | -$13.39M | -$0.12 | 2.24% | 8.73% | N/A | N/A | |
| TENB | TENABLE HOLDINGS INC | A | A | $3.22B | $974.60M | $51.10M | -$33.51M | -$0.28 | 11.05% | 18.38% | N/A | N/A | |
| COMM | COMMSCOPE HOLDING COMPANY INC | A | A | $3.72B | $5.30B | $1.70B | $888.60M | $4.10 | 33.82% | -9.24% | N/A | N/A | |
| OPRX | OPTIMIZERX CORP | A | A | $282.97M | $109.51M | $11.65M | $34.00k | $0.00 | 24.18% | 26.16% | N/A | N/A | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | A | A | $3.06B | $317.93M | -$24.00M | -$44.32M | -$0.35 | 129.21% | N/A | N/A | N/A | |
| SHC | SOTERA HEALTH CO | A | A | $4.44B | $1.15B | $428.10M | $55.43M | $0.20 | 2.67% | 7.68% | -20.00% | N/A | |
| TG | TREDEGAR CORP | A | A | $297.09M | $588.92M | -$33.93M | -$53.79M | -$1.58 | 22.75% | -3.32% | N/A | N/A | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | A | $1.49B | $599.82M | $83.87M | -$8.78M | -$0.05 | 45.38% | 62.14% | N/A | N/A | |
| CAH | CARDINAL HEALTH INC | A | A | $48.79B | $234.31B | $3.25B | $1.60B | $6.66 | 4.39% | 8.67% | 26.86% | 14.94% | |
| ONC | BEONE MEDICINES LTD | A | A | $40.52B | $4.97B | $318.03M | $68.55M | $0.05 | 49.92% | 79.66% | N/A | N/A | |
| MIRM | MIRUM PHARMACEUTICALS INC | A | A | $3.67B | $471.79M | -$592.00k | -$41.42M | -$0.85 | 53.66% | N/A | N/A | N/A | |
| AMRN | AMARIN CORP PLC | A | A | $339.75M | $226.73M | -$80.28M | -$86.19M | -$4.20 | -5.93% | -17.41% | N/A | N/A | |
| AENT | ALLIANCE ENTERTAINMENT HOLDING CORP | A | A | $707.91M | $1.09B | $45.34M | $19.56M | $0.40 | -1.29% | N/A | 135.29% | N/A | |
| EMBC | EMBECTA CORP | A | A | $850.34M | $1.08B | $209.00M | $52.80M | $0.90 | -4.68% | N/A | -26.23% | N/A | 2025-12-23 |
| CSTM | CONSTELLIUM SE | A | A | $2.12B | $8.03B | $636.48M | $120.18M | $0.86 | 8.64% | 8.31% | -4.11% | N/A | |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | A | $370.38M | $474.54M | $45.27M | $15.09M | $0.84 | 6.62% | 4.81% | -5.62% | 0.00% | |
| ALNT | ALLIENT INC | A | A | $898.01M | $533.13M | $63.38M | $18.66M | $1.13 | -2.88% | 8.07% | 26.97% | 2.27% | |
| HAS | HASBRO INC | A | A | $10.91B | $4.36B | -$58.90M | -$558.30M | -$3.97 | 0.79% | -3.37% | N/A | N/A | |
| ANIP | ANI PHARMACEUTICALS INC | A | A | $1.89B | $826.88M | $165.21M | $39.01M | $1.71 | 48.87% | 32.93% | N/A | N/A | |
| NVT | NVENT ELECTRIC PLC | A | A | $17.19B | $3.58B | $1.08B | $602.10M | $3.67 | 21.54% | 11.85% | 5.76% | N/A | |
| ELAN | ELANCO ANIMAL HEALTH INC | A | A | $10.48B | $4.59B | $840.00M | $36.00M | $0.07 | 3.08% | 9.46% | -82.93% | N/A | |
| PD | PAGERDUTY INC | A | A | $1.44B | $483.61M | $16.78M | -$13.88M | -$0.15 | 8.20% | 20.65% | N/A | N/A | 2025-11-25 |
| FRSH | FRESHWORKS INC | A | A | $3.41B | $810.64M | $25.26M | -$29.62M | -$0.11 | 18.18% | N/A | N/A | N/A | |
| VVX | V2X INC | A | A | $1.71B | $4.42B | $295.19M | $80.14M | $2.54 | 5.10% | 25.75% | 775.86% | -0.99% | |
| BCO | BRINKS CO | A | A | $4.63B | $5.15B | $806.70M | $170.10M | $3.99 | 3.07% | 7.38% | 47.78% | N/A | |
| SPNT | SIRIUSPOINT LTD | A | A | $2.37B | $2.84B | $339.10M | $182.30M | $1.66 | 7.87% | 30.11% | 0.00% | 32.93% | |
| RNG | RINGCENTRAL INC | A | A | $2.36B | $2.49B | $314.24M | $13.24M | $0.15 | 5.45% | 17.67% | N/A | N/A | |
| RSI | RUSH STREET INTERACTIVE INC | A | A | $3.96B | $1.06B | -$33.04M | $30.09M | $0.33 | 23.15% | 42.91% | N/A | 75.18% | |
| JOUT | JOHNSON OUTDOORS INC | A | A | $394.87M | $562.53M | -$23.64M | -$39.51M | -$3.87 | -3.56% | 1.06% | N/A | N/A | 2025-12-05 |
| BSBR | BANCO SANTANDER (BRASIL) SA | A | A | $47.44B | $73.76B | $21.87B | $13.37B | N/A | 11.98% | 4.65% | N/A | N/A | |
| YEXT | YEXT INC | A | A | $1.04B | $449.66M | $49.20M | $7.45M | $0.07 | 13.51% | 6.31% | N/A | N/A | 2025-12-09 |
| PAHC | PHIBRO ANIMAL HEALTH CORP | A | A | $1.83B | $1.40B | $183.09M | $67.82M | $1.67 | 33.71% | 11.68% | 288.37% | 9.52% | |
| DLX | DELUXE CORP | A | A | $909.60M | $2.12B | $393.66M | $82.74M | $1.85 | -0.94% | 2.66% | 48.00% | 87.42% | |
| NMRK | NEWMARK GROUP INC | A | A | $2.96B | $3.16B | $361.12M | $103.62M | $0.60 | 20.95% | 10.30% | 93.55% | 12.03% | |
| PCRX | PACIRA BIOSCIENCES INC | A | B | $1.02B | $716.79M | $150.99M | $21.44M | $0.46 | 3.14% | 11.22% | N/A | -30.95% | |
| SSRM | SSR MINING INC | A | B | $4.32B | $1.43B | $443.03M | $219.85M | $1.08 | 30.30% | 16.74% | N/A | 4.66% | |
| FIX | COMFORT SYSTEMS USA INC | A | B | $32.08B | $8.32B | $1.21B | $837.62M | $23.67 | 27.71% | 23.67% | 80.55% | 43.80% | |
| CCLD | CARECLOUD INC | A | B | $132.70M | $114.32M | $27.79M | $2.38M | $0.04 | 2.97% | 5.17% | N/A | N/A | |
| KALU | KAISER ALUMINUM CORP | A | B | $1.48B | $3.21B | $280.90M | $91.40M | $5.66 | 7.69% | 20.38% | 70.48% | 47.89% | |
| MATV | MATIV HOLDINGS INC | A | B | $697.18M | $1.98B | -$252.80M | -$436.50M | -$8.03 | 0.39% | 13.91% | N/A | N/A | |
| HCI | HCI GROUP INC | A | B | $2.33B | $816.58M | $301.16M | $203.94M | $17.26 | 8.75% | 21.90% | 16.23% | 33.77% | |
| CMRC | COMMERCECOM INC | A | B | $399.00M | $339.86M | $12.34M | -$13.37M | -$0.16 | 2.97% | 19.37% | N/A | N/A | |
| IMAX | IMAX CORP | A | B | $1.88B | $377.68M | $124.88M | $39.55M | $0.73 | 9.30% | 12.97% | 65.91% | N/A | |
| DBD | DIEBOLD NIXDORF INC | A | B | $2.33B | $3.69B | $303.10M | $50.60M | $1.39 | -2.86% | N/A | 13,800.00% | N/A | |
| RAMP | LIVERAMP HOLDINGS INC | A | B | $1.89B | $778.79M | $64.50M | $40.11M | $0.62 | 10.13% | 13.58% | 1,140.00% | N/A | |
| DINO | HF SINCLAIR CORP | A | B | $10.33B | $26.90B | $1.63B | $393.49M | $2.13 | -9.53% | 16.26% | 26.79% | N/A | |
| STRT | STRATTEC SECURITY CORP | A | B | $277.86M | $578.41M | $45.84M | $23.51M | $5.82 | 6.83% | 8.11% | 46.60% | N/A | |
| MDXG | MIMEDX GROUP INC | A | B | $1.09B | $393.44M | $69.21M | $40.83M | $0.28 | 14.77% | 8.97% | -55.56% | N/A | |
| JBL | JABIL INC | A | B | $21.57B | $29.80B | $1.71B | $657.00M | $6.00 | 3.18% | 1.79% | -47.09% | 75.54% | 2025-12-11 |
| NVST | ENVISTA HOLDINGS CORP | A | B | $3.19B | $2.62B | $341.10M | $15.30M | $0.09 | 4.73% | 8.92% | N/A | N/A | |
| INDV | INDIVIOR PLC | A | B | $3.81B | $1.18B | $316.00M | $166.00M | $1.31 | -0.17% | N/A | N/A | N/A | |
| CYD | CHINA YUCHAI INTERNATIONAL LTD | A | B | $1.37B | $2.62B | $100.08M | $44.19M | $1.12 | 2.97% | 0.36% | 14.10% | -11.87% | 2025-11-17 |
| HCSG | HEALTHCARE SERVICES GROUP INC | A | B | $1.22B | $1.81B | $73.01M | $39.74M | $0.55 | 6.26% | 0.27% | -21.43% | -14.59% | |
| MCFT | MASTERCRAFT BOAT HOLDINGS INC | A | B | $302.89M | $287.85M | $29.07M | $15.82M | $0.97 | -1.89% | -4.22% | N/A | N/A | |
| MG | MISTRAS GROUP INC | A | B | $392.77M | $715.30M | $69.50M | $18.13M | $0.58 | -3.20% | 3.21% | 61.11% | N/A | |
| FOLD | AMICUS THERAPEUTICS INC | A | B | $2.92B | $598.70M | $59.28M | -$14.06M | -$0.04 | 21.28% | 19.51% | N/A | N/A | |
| OOMA | OOMA INC | A | B | $313.54M | $261.62M | $11.60M | -$1.51M | -$0.06 | 5.42% | 10.07% | N/A | N/A | 2025-12-03 |
| GMED | GLOBUS MEDICAL INC | A | B | $11.30B | $2.77B | $731.92M | $423.78M | $3.13 | 11.75% | 29.27% | 404.84% | 26.66% | |
| AVAH | AVEANNA HEALTHCARE HOLDINGS INC | A | B | $1.77B | $2.29B | $268.44M | $75.46M | $0.38 | 15.48% | N/A | N/A | N/A | |
| TXT | TEXTRON INC | A | B | $14.22B | $14.24B | $1.50B | $827.00M | $4.60 | 1.83% | 3.45% | -0.43% | 31.05% | |
| TBLA | TABOOLACOM LTD | A | B | $1.16B | $1.88B | $137.29M | $25.29M | $0.08 | 10.96% | N/A | N/A | N/A | |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | A | B | $29.15B | $16.78B | $2.90B | $712.00M | $0.63 | 0.02% | 0.12% | N/A | N/A | |
| APTV | APTIV PLC | A | B | $17.05B | $20.15B | $2.23B | $295.00M | $1.33 | 2.16% | 10.11% | -85.17% | -27.57% | |
| SEB | SEABOARD CORP | A | B | $3.95B | $9.82B | $811.00M | $397.00M | $410.47 | 10.31% | 7.16% | N/A | 18.73% | |
| BGC | BGC GROUP INC | A | B | $4.24B | $2.76B | $435.13M | $165.79M | $0.34 | 24.93% | 5.96% | 36.00% | 41.47% | |
| EZPW | EZCORP INC | A | B | $1.08B | $1.27B | $261.61M | $109.61M | $1.91 | 9.70% | 9.14% | 26.49% | N/A | 2025-11-19 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | A | B | $1.45B | $757.07M | $336.13M | $58.44M | $1.85 | 26.34% | 19.71% | -31.73% | 29.40% | |
| PTC | PTC INC | A | B | $21.52B | $2.47B | $885.58M | $512.73M | $4.26 | 11.42% | 12.00% | 71.77% | 41.16% | |
| MOG.A | MOOG INC | A | B | $6.38B | $3.73B | $436.71M | $211.62M | $6.66 | 4.77% | 4.88% | 4.39% | 11.70% | |
| KN | KNOWLES CORP | A | B | $1.84B | $573.50M | $101.60M | $41.70M | $0.47 | 4.23% | -5.35% | N/A | N/A | |
| ANAB | ANAPTYSBIO INC | A | B | $936.42M | $169.47M | -$82.14M | -$84.63M | -$2.74 | 196.42% | 56.59% | N/A | N/A | |
| AMRX | AMNEAL PHARMACEUTICALS INC | A | B | $3.66B | $2.93B | $503.93M | $5.90M | $0.02 | 9.50% | 9.32% | N/A | -46.59% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | A | B | $510.81M | $338.99M | $130.50M | $28.55M | $0.19 | -10.42% | -3.21% | N/A | -23.18% | |
| VTEX | VTEX | A | B | $729.67M | $234.04M | -$12.77M | $10.12M | $0.11 | 3.93% | N/A | 103.70% | N/A | |
| SNDK | SANDISK CORP | A | B | $37.25B | $7.78B | -$1.38B | -$1.74B | N/A | 10.94% | N/A | N/A | N/A | |
| PRLB | PROTO LABS INC | A | B | $1.15B | $518.38M | $57.15M | $14.84M | $0.63 | 2.82% | 3.28% | -33.68% | -21.47% | |
| MGA | MAGNA INTERNATIONAL INC | A | B | $13.83B | $41.79B | N/A | $1.03B | $3.66 | -2.04% | 5.83% | -2.40% | 19.69% | |
| EWCZ | EUROPEAN WAX CENTER INC | A | B | $206.57M | $211.26M | $61.39M | $11.24M | $0.26 | -5.47% | N/A | 13.04% | N/A | |
| GNE | GENIE ENERGY LTD | A | B | $386.83M | $483.28M | $8.68M | $4.85M | $0.20 | 13.12% | 6.16% | 150.00% | -17.40% | |
| TBRG | TRUBRIDGE INC | A | B | $305.73M | $349.88M | $51.45M | $5.58M | $0.36 | 3.88% | 5.46% | N/A | -25.23% | |
| ORLA | ORLA MINING LTD | A | B | $4.10B | $772.15M | $326.32M | $53.74M | $0.16 | 145.83% | N/A | 700.00% | N/A | |
| PRIM | PRIMORIS SERVICES CORP | A | B | $6.38B | $7.46B | $513.21M | $277.14M | $5.13 | 21.45% | 17.12% | 67.10% | 20.25% | |
| FCFS | FIRSTCASH HOLDINGS INC | A | B | $7.06B | $3.49B | $975.42M | $309.75M | $6.96 | 3.86% | 14.95% | 28.18% | 18.02% | |
| VRT | VERTIV HOLDINGS CO | A | B | $65.37B | $9.70B | $1.82B | $1.03B | $2.71 | 28.76% | 18.01% | 75.97% | N/A | |
| TPR | TAPESTRY INC | A | B | $20.75B | $7.21B | $598.20M | $271.40M | $1.36 | 8.14% | 8.58% | -61.36% | N/A | |
| VIAV | VIAVI SOLUTIONS INC | A | B | $3.77B | $1.15B | $98.00M | $15.20M | $0.07 | 15.60% | 0.42% | N/A | -23.66% |
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
It’s little wonder that growth stocks have a reputation as exciting, high-reward investing opportunities. After all, some of the most successful stocks — think Amazon (NASDAQ: AMZN), Tesla (NASDAQ: TSLA), and Nvidia (NASDAQ: NVDA) — started as growth stocks.
However, not every stock experiencing rapid development will go on to dominate the stock market. The potential for high rewards comes with increased risk. A company showing high revenue growth doesn’t necessarily equal a great investment.
Keep reading to learn:
A growth stock is a company whose revenue, earnings, or market share is expanding at a significantly faster rate than the market average or its industry peers.
Companies that prioritize rapid revenue and earnings growth often reinvest profits instead of paying dividends, betting their money on expansion, innovation, and market dominance.
In the stock market, a security's success can last for minutes — or decades. How can you tell the difference between a stock that's portfolio-worthy for the long haul versus one fueled by temporary market hype?
True growth stocks typically have strong fundamentals, such as consistent revenue growth, expanding profit margins, and a competitive edge (for example, proprietary technology or brand dominance). They also have a scalable business model and demonstrate resilience across market cycles, such as during periods of high interest rates or other major economic events.
In contrast, stocks driven by temporary market trends — say, meme stocks or companies capitalizing on short-lived trends — often rely on speculative momentum but lack solid financials and struggle to sustain growth once the fad fades. The decline can happen fast — for instance, a company that was killing it in the fourth quarter could report a net loss by their next earnings report.
Here are some characteristics to look for before you buy:
Perhaps the biggest misconception in growth investing is that the best way to generate fast returns is to buy shares of the fastest-growing companies.
In reality, stocks with the highest projected growth rates tend to deliver the worst stock price performance. At first glance, this might seem like a strange concept, so let’s break it down.
When a company is expected to grow earnings by 30%+ per year, its stock experiences a surge in price, often experiencing a powerful period of price appreciation. But it is often unsustainable.
Why? Because the competition takes notice, adapts, and fights to gain market share. Maintaining that pace becomes nearly impossible.
Even if a company’s growth slows from 30% to a still-impressive 20%, it can be catastrophic for the stock if investors and analysts pricing it for higher expectations. The moment those investors and analysts realize the period of extreme growth is over, you can safely expect them to move on — and the stock price can collapse.
So, if you shouldn't buy solely based on rapid expansion and price action, what should you look for? Consistent, sustainable growth.
As for how to identify it…
Identifying stocks with growth potential requires a combination of research, analysis, and due diligence.
Our Best Stocks to Buy Now for High Growth screener can help you easily focus on stocks with a high Zen Rating for Growth.
As part of its overall 115-factor review of the 4600+ stocks we track, our quant model assesses 21 different measures of Growth. It considers sales and earnings growth, but it also looks for gains in revenue, cash flow, profit margins, and EBITDA to ensure that companies with strong or underrated growth prospects make the cut.
After all, the more consistent these gains, particularly across multiple growth measures, the more likely the stock's price will continue to appreciate.
However, that doesn’t tell the whole story. That’s why it’s important to take a big-picture view.
This may sound counterintuitive, but when looking for high-quality growth stocks to buy, it’s worth considering more than just growth, such as:
Zen Ratings can help you gain this type of bigger-picture view. In addition to reviewing 22 Growth Factors, it also zeroes in on 93 other Factors that can greatly increase the likelihood of outperforming the market, including 21 Value Factors, 26 Financial Factors, and more.
Locating the best growth stocks isn’t just about locating the most impressive price action in the market.
Our Best Growth Stocks to Buy Now screener can help you quickly locate stocks to buy, but it’s important to remember that growth doesn’t exist in a vacuum — you must consider the big picture.
Growth-oriented investors should seek stocks that display an overall A or B rating while also scoring A or B for Growth. However, you should also consider other factors that may support growth, such as Financials, Momentum, and Sentiment.
If you're looking for guidance in choosing high-quality stocks, consider becoming a Zen Investor member. The portfolio includes hand-picked stocks that have passed a rigorous screening process that considers criteria like valuation, performance, what analysts are saying, and more. Save time and energy — Gain access to the market-beating Zen Investor portfolio now.